Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis <scp>B</scp> vaccine in inflammatory bowel disease patients

Patrícia Andrade, João Santos‐Antunes, Susana Rodrigues, Susana Lopes, Guilherme Macedo

Journal of Gastroenterology and Hepatology · 2015 · 63 citations · 24 references

Abstract

The response rate to the standard HBV vaccination in IBD patients is low mainly in those treated with infliximab and/or azathioprine.

References

24